Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-07-03 Sale | 2023-07-03 7:43 pm | Icosavax Inc. | ICVX | Holtzman Douglas Chief Scientific Officer | 16,356 | $8.8495 | $144,743 | 321,467 (Indirect Direct) | View |
| 2023-04-03 Sale | 2023-04-05 7:12 pm | Icosavax Inc. | ICVX | Holtzman Douglas Chief Scientific Officer | 20,443 | $6.0856 | $124,407 | 337,823 (Indirect Direct) | View |
| 2023-02-13 Sale | 2023-02-15 8:07 pm | Icosavax Inc. | ICVX | Holtzman Douglas Chief Scientific Officer | 4,871 | $10.33 | $50,338 | 292,846 (Indirect Direct) | View |
| 2022-12-15 Sale | 2022-12-16 6:36 pm | Icosavax Inc. | ICVX | Holtzman Douglas Chief Scientific Officer | 19,648 | $11.14 | $218,963 | 296,050 (Indirect Direct) | View |
| 2022-07-29 Sale | 2022-08-02 9:42 pm | Icosavax Inc. | ICVX | Holtzman Douglas Chief Scientific Officer | 10,375 | $6.6668 | $69,168 | 315,698 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-07-03 Exercise | 2023-07-03 7:43 pm | N/A 2031-01-28 | Icosavax Inc. | ICVX | Holtzman Douglas Chief Scientific Officer | 16,356 | $0 | 321,467 (Direct) | View |
| 2023-07-03 Exercise | 2023-07-03 7:43 pm | N/A N/A | Icosavax Inc. | ICVX | Holtzman Douglas Chief Scientific Officer | 16,356 | $1.04 | 321,467 (Direct) | View |
| 2023-04-03 Exercise | 2023-04-05 7:12 pm | N/A 2031-01-28 | Icosavax Inc. | ICVX | Holtzman Douglas Chief Scientific Officer | 20,443 | $0 | 337,823 (Direct) | View |
| 2023-04-03 Exercise | 2023-04-05 7:12 pm | N/A N/A | Icosavax Inc. | ICVX | Holtzman Douglas Chief Scientific Officer | 20,443 | $1.04 | 337,823 (Direct) | View |
| 2023-02-15 Option Award | 2023-02-17 7:08 pm | N/A 2033-02-14 | Icosavax Inc. | ICVX | Holtzman Douglas Chief Scientific Officer | 90,000 | $0 | 90,000 (Direct) | View |
| 2022-05-31 Ownership | 2023-02-14 5:15 pm | N/A N/A | Icosavax Inc. | ICVX | Holtzman Douglas Chief Scientific Officer | 1,667 | $5.77 | 297,717 (Direct) | View |
Ownership | 2023-02-14 5:15 pm | N/A N/A | Icosavax Inc. | ICVX | Holtzman Douglas Chief Scientific Officer | 0 | $0 | 297,717 (Indirect) | View |
| 2022-11-10 Option Award | 2022-11-14 6:58 pm | N/A 2032-11-09 | Icosavax Inc. | ICVX | Holtzman Douglas Chief Scientific Officer | 82,580 | $0 | 82,580 (Direct) | View |
| 2022-02-18 Gift | 2022-08-02 9:42 pm | N/A N/A | Icosavax Inc. | ICVX | Holtzman Douglas Chief Scientific Officer | 20,000 | $0 | 315,698 (Indirect) | View |
| 2022-02-10 Option Award | 2022-02-14 7:04 pm | N/A 2032-02-09 | Icosavax Inc. | ICVX | Holtzman Douglas Chief Scientific Officer | 101,435 | $0 | 428,023 (Direct) | View |
| 2021-12-31 Gift | 2022-02-14 7:04 pm | N/A N/A | Icosavax Inc. | ICVX | Holtzman Douglas Chief Scientific Officer | 10,000 | $0 | 428,023 (Indirect) | View |
| 2021-07-30 Option Award | 2021-08-02 9:26 pm | N/A N/A | Icosavax Inc. | ICVX | Holtzman Douglas Chief Scientific Officer | 41,500 | $15 | 334,922 (Direct) | View |
| 2021-08-02 Conversion | 2021-08-02 9:26 pm | N/A N/A | Icosavax Inc. | ICVX | Holtzman Douglas Chief Scientific Officer | 270,365 | $0 | 334,922 (Indirect) | View |
Ownership | 2021-07-28 9:22 pm | N/A N/A | Icosavax Inc. | ICVX | Holtzman Douglas Chief Scientific Officer | 0 | $0 | 651,785 (Direct) | View |